Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Voydeya approved in US

2 April 2024 Voydeya approved in the US as add-on therapy to ravulizumab or eculizumab for treatment of extravascular haemolysis in adults with the rare disease PNH Approval of first-in-class, oral, Factor D inhibitor based on results from pivotal ALPHA Phase III trial Voydeya (danicopan) has been approved in the US as add-on therapy to ravulizumab or eculizumab for the treatment of extravascular haemolysis (EVH) in adults with paroxysmal nocturnal haemoglobinuria (PNH).[1] Voydeya is a first-in-class, oral, Factor D inhibitor developed as an add-on to standard-of-care Ultomiris (

AFRY is the trusted partner for TNB Renewables in a new solar power project in Malaysia

TNB Renewables Sdn Bhd has appointed AFRY as the owner’s engineer for the construction of a large-scale solar photovoltaic plant in Kedah, Malaysia, that will provide clean energy to a corporate consumer through a long-term agreement.TNB Renewables Sdn Bhd (TRe) is a fully owned subsidiary of Malaysia’s leading electricity utility company, Tenaga Nasional Berhad (TNB), that has a firm commitment to accelerating the transition to sustainable energy in the country and across Southeast Asia. TRe has chosen AFRY to provide owner’s engineering services on the Corporate Green Power Programme (

FDA accepts Dato-DXd BLA for breast cancer

2 April 2024 Datopotamab deruxtecan Biologics License Application accepted in the US for patients with previously treated metastatic HR-positive, HER2-negative breast cancer Application based on results from the TROPION-Breast01 Phase III trial Additional BLA under review in the US for AstraZeneca and Daiichi Sankyo's datopotamab deruxtecan for patients with advanced nonsquamous non-small cell lung cancer AstraZeneca and Daiichi Sankyo's Biologics License Application (BLA) for datopotamab deruxtecan (Dato-DXd) has been accepted in the US for the treatment of adult patients with

Notice of annual general meeting 2024 in Camurus (publ)

The shareholders of Camurus AB (publ), Reg. No 556667-9105, are hereby invited to the Annual General Meeting (“AGM”) on 8 May 2024 at 17.00 CEST at Elite Hotel Ideon, Scheelevägen 27, Ideon Science Park, 223 63 Lund, Sweden. Registration for the AGM begins at 16.30 CEST. The Board of Directors has decided that shareholders shall be able to exercise their voting rights at the AGM also by postal voting in accordance with the regulations in Camurus’ Articles of Association. Right to participate and notification A) Participation in the meeting room A person who wishes to attend the

PostNord releases ABBA Stamps – celebrating 50 years of music history

Every year, PostNord releases a number of stamps featuring a motif that illustrates someone or something that has meant a little bit extra to Sweden. It can be a person, a happening, or an event stemming from Swedish nature, culture, history, sports, or society. To celebrate 50 years of iconic pop music beloved by listeners worldwide, PostNord has chosen the music group ABBA as a motif this year.ABBA has had a tremendous impact on both Sweden and the global music scene over the past 50 years – a success story that began with the performance of "Waterloo" at the Eurovision Song Contest in

Events during the first quarter, 2024

During the quarter, Wallenstam has completed two new construction projects in Gothenburg and Uppsala as well as the reconstruction and extension of a commercial property in central Gothenburg. All in all, Wallenstam had 830 apartments under construction as of March 31, 2024. Wallenstam’s repurchase of its own shares that started on October 20, 2023 has now ended.The Kv.5 project in Kallebäcks Terrasser, Gothenburg, which comprises 182 apartments, has been completed during the quarter, as has the Kompositören project in Uppsala where the last 69 apartments out of a total of 185 are now

Transaction in Own Shares

    02 April 2024 Vesuvius plc Share Buyback Programme – Transactions in Own Securities   Vesuvius plc (the "Company") announces that it has purchased the following number of its Ordinary Shares of 10p each from Jefferies International Limited (the “Broker”), pursuant to the terms of its Share Buyback Programme announced on 4 December 2023:   +---------------------------------------------------------------+----------+|Date of purchase: |28/03/2024|+-------------------------------------------------------------

Repurchases of shares by Concentric AB during week 13, 2024 – third leg of the buy back completed

Between 25 March 2024 and 28 March 2024 Concentric AB (LEI code 5493002G9GMTKIP3PW19) (“Concentric”) has repurchased in total 13,339 own shares (ISIN: SE0003950864) as part of the repurchase program initiated by the Board. The repurchases form part of the repurchase program of a maximum of 3,519,172 own shares for a total maximum amount of SEK 150,000,000 that Concentric announced on 26 July 2023. The repurchase program, which runs between 31 July 2023 and 31 March 2024, is being carried out in accordance with the Market Abuse Regulation (EU) No 596/2014 and the Commission Delegated

Invitation to Autoliv’s Q1, 2024 Earnings Call

(Stockholm, Sweden, April 2, 2024) – Autoliv Inc., plans to publish its Financial Report for the first quarter 2024 on Friday, April 26, 2024 at 12:00 Central European Time (CET).The report will be available at www.autoliv.comIn addition, a teleconference will take place the same day. Q1 2024 Earnings Call:Date: April 26, 2024Time: 14:00 – 15:00 CETMain speaker: Mikael Bratt, President & CEO To attend by webcast, please usethe link on our web or the linkbelow:https://edge.media-server.com/mmc/p/u3ygbhjnTo attend by phone, use the linkbelow to

Studsvik appoints new CFO

Studsvik has appointed Peter Teske as Chief Financial Officer and member of the Studsvik Executive Management Group. He will start his appointment 29[th] of April 2024. Peter comes most recently from a position at Skill Scandinavia as CFO. Prior to that, he held various senior positions in the field of economics and finance in both the private and public sectors. "Studsvik is in a period of focus on growth, efficiency and change. Peter will be a reinforcement to the Group with his experience of both finance and change management in various types of businesses," comments Camilla

Metso and Almalyk MMC sign frame agreement for major copper smelter delivery in Uzbekistan

Metso Corporation’s press release on April 2, 2024, at 09:00 a.m. EESTMetso and JSC Almalyk Mining and Metallurgical company (Almalyk MMC) have signed a frame agreement on significant process technology deliveries for Almalyk MMC’s new copper smelter investment in Uzbekistan. The companies have collaborated on the development of minerals processing and metallurgical operations since 2011. Equipment package contracts under the framework agreement will be booked once they have been signed and become effective. We currently estimate that the majority of those contracts will be signed this

Major turnaround 2024 at Neste refinery in Porvoo, Finland about to begin

Neste Corporation, Press Release, 2 April 2024 at 9 a.m. (EET)Neste secures safe and undisrupted operations at its refineries with regularly scheduled maintenance shutdowns, i.e. major turnarounds. At Neste’s refinery in Porvoo, Finland, the preparations for the major turnaround  taking place in April-June began on 1 April with shutdowns of process units. After the refinery shutdown is completed, the actual turnaround works will begin in mid-April and are expected to continue

Teleste Corporation´s conveyance of own shares based on the long-term incentive plan

Teleste CorporationStock exchange releaseApril 2, 2024, at 9:00 a.m. EEST  TELESTE CORPORATION´S CONVEYANCE OF OWN SHARES BASED ON THE LONG-TERM INCENTIVE PLAN A total of 8,628 Teleste Corporation's treasury shares were conveyed without consideration to the key employees participating in the plan period 2021–2023 of Teleste long-term share-based incentive programme. More detailed information about the launch of the plan period and its terms and conditions is available in a stock exchange release published on 11 February 2021. The decision on the directed share issue is based

BerGenBio ASA secures underwriting of NOK 118 million gross proceeds representing minimum 80% exercise of the remaining Warrants, providing funding into 2H 2025

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CHINA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS ANNOUNCEMENT. Bergen, Norway - 2 April 2024: Reference is made to the stock exchange announcement from BerGenBio ASA (the "Company") dated 14 June 2023 regarding the final results of the rights issue of 2,500,000,000 new shares in

Tecnotree Oyj - Managers' Transactions - Ravichander

Tecnotree Corporation Stock Exchange Release 2 April 2024 at 8:45 EESTPerson subject to the notification requirementName: Padma RavichanderPosition: Chief Executive Officer Issuer: Tecnotree OyjLEI: 743700MRPVYI7ASHCX38Notification type: INITIAL NOTIFICATIONReference number: 743700MRPVY17ASHCX38_20240401165010_8 ____________________________________________Transaction date: 2024-03-27Venue: OFF-EXCHANGE TRANSACTIONS (XOFF)Instrument type: DEBT INSTRUMENTISIN: FI0009010227Nature of transaction: DISPOSAL  Transaction details(1): Volume: 30 Unit price: 100000 EUR

Lea bank ASA - Notice of annual general meeting

Lea bank's shareholders are hereby given notice of the annual general meeting to be held on April 17 2024, at 10:00 AM CET (the "GM") at the bank's offices at Holbergs gate 21, 0166 Oslo. Please see attached notice of the GM. The notice will be sent electronically or by mail to all shareholders with a known address. The notice and other documents related to the agenda are also available at leabank.no/about-us/investor-relations/general-meeting. Contact Information: Oddbjørn Berentsen, CEO Phone: +47 22 99 14 00 Email: ir@leabank.no

Tele2 Annual and Sustainability Report 2023

Stockholm – Tele2 AB (“Tele2”) (Nasdaq Stockholm: TEL2 A and TEL2 B) today published its 2023 Annual and Sustainability Report. The report is available at www.tele2.com.Highlights from the 2023 Annual Report · End-user service revenue of SEK 21,130 million increased by 4% compared to full year 2022 on an organic basis primarily driven by strong performance in the Baltics and Sweden B2B. · Tele2's Sweden Consumer business strategically positioned for growth in fixed-mobile convergence through digitalization and investing in IT systems to enhance customer experience with efficient and

Peptonic Medical AB strengthens its position in Europe through an exclusive distribution agreement for VagiVital and Vernivia in the Benelux region

Peptonic Medical AB (publ) ("Peptonic") has signed an exclusive distribution agreement with FirstAid4All to launch Peptonic's products in intimate self-care in Belgium, the Netherlands, and Luxembourg. The products will be distributed under Peptonic's brand, VagiVital and Vernivia. The partnership underscores Peptonic's strategy to expand its geographic presence and strengthen its market position in Europe through collaboration with selected partners. The first order to FirstAid4All will be delivered this week.Peptonic announced today that the company has signed an exclusive distribution

Ellevio announces a cash offer of SEK 90 per share to the shareholders of Dala Energi

The Offer is not being made, and this press release may not be distributed, directly or indirectly, in or into, nor will any tender of shares be accepted from or on behalf of shareholders in Australia, Hong Kong, Japan, Canada, New Zealand, the United States or South Africa, or any other jurisdiction in which the making of the Offer, the distribution of this press release or the acceptance of any tender of shares in the Offer would contravene applicable laws or regulations or require further offer documents, filings or other measures in addition to those required under Swedish law.The

SSAB continues the transformation with a fossil-free mini-mill in Luleå, Sweden

SSAB’s Board of Directors have today taken the decision to proceed with the next step in SSABs transition, building a state-of-the-art fossil-free mini-mill in Luleå, Sweden. When completed SSAB will close the current blast furnace-based production system. This will reduce Sweden’s CO\2\ emissions with 7% in addition to the 3% from the Oxelösund mill conversion. The new Luleå mill will have a capacity of 2.5 mton/year and consist of two electric arc furnaces, advanced secondary metallurgy, a direct strip rolling mill to produce SSABs specialty products, and a cold rolling complex

Smooth, sustainable and user-friendly future mobility under way in Tampere, Finland

Press release 2nd April 2024 at 8:15 Reaching of emission and sustainability targets are a challenge for both urban development and transport performance. New solutions are needed to deliver mobility services tailored to users and sustainable, safe and smooth urban transport. The Finnish Smart Rail Ecosystem has set itself the goal of creating the world's best tram in terms of passenger experience and life-cycle services.SmartRail, a network and ecosystem  formed by Škoda Transtech, the City of Tampere, Tampere University, VTT Technical Research Centre of

OssDsign awarded long-term agreement with Premier, Inc.

Uppsala, Sweden, April 2 – OssDsign AB (publ.) today announces that the company has been awarded a new group purchasing (GPO) agreement for Bone and Bone Substitute Implantable Products with Premier, Inc., a leading U.S. healthcare improvement company uniting an alliance of approximately 4,350 U.S. hospitals and health systems and more than 300,000 other providers and organizations. The agreement is for a period of three years.Effective July 1, 2024, the agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for

Hansa Biopharma Expects Strong First Quarter 2024 Sales Performance

Company expects revenue of SEK 54m including product sales of SEK 48m - an increase of 10% versus the prior quarter and a 234% increase versus Q1 2023 Q1 2024 is the first time Hansa has delivered two consecutive quarters of strong revenue and growthLund, Sweden, April 2, 2024, Hansa Biopharma AB (Nasdaq Stockholm: HNSA) expects to report revenue of approximately SEK 54m for Q1 ending March 31, 2024 (preliminary and unaudited), consisting of SEK 48m in product sales and SEK 6m in revenue recognition primarily related to its agreement with Sarepta Therapeutics, Inc. Revenue growth during

There are no items matching the current filter
There are no more items matching the current filter
Back to top